the phosphorus supplements only intermittently, but her condition remained stable until June 1967 when her pain increased, particularly in the left thigh. X-rays showed the development of new Looser zones in the right metatarsus and neck of the left femur and an increase in the zones of the femoral shafts. On readmission to hospital in September 1967, the Looser zone of the left femoral neck had developed into a frank fracture (Fig 2) . She admitted she had not been taking her sodium phosphate supplements. On examination: no change apart from signs related to the fracture.
Investigations: Serum calcium 12-0 mg/100 ml (normal range at that time 10-12). Inorganic phosphate 2-2 mg/100 ml. Alkaline phosphatase 9 9 K-A units. Blood urea 40 mg/100 ml. Urinary calcium 560, urinary phosphorus 861 mg/24 hours.
A diagnosis of relapse of osteomalacia in spite of vitamin D overdosage was made. With oral sodium phosphate (1-5 g phosphorus), the urinary calcium fell to 293 mg/24 hours. On substitution of hydrocortisone 160 mg a day for vitamin D, the urinary calcium fell to 171 mg/24 hours and stayed at this level when all three were stopped. Serum calcium fell from 12-0 to 10-2 mg/100 ml. On restarting vitamin D (2-5 mg/24 hours), the urinary calcium rose to 510 mg/24 hours, but with phosphate (1-5 g phosphorus in 24 hours) it fell to 378 mg/24 hours. The dose of vitamin D has gradually been reduced to 1 mg a day and the added phosphate supplements left unaltered.
Urinary calcium fell progressively before and after discharge to 83 mg/24 hours on 21.8.68. Serum calcium remained within normal limits. The fractured femur was treated with traction only. Both this (Fig 3) and the fractures in the right foot healed in the six-month period after her admission.
Characterization of a Myeloma Protein P Torkington MA MB (St James' Hospital, Balham, London) Woman, aged 68 Presented with breathlessness and pallor of one month's duration. Clinical examination revealed marked anemia. The urine contained abundant protein, a few pus cells and red blood cells. No Bence-Jones protein was detected.
Investigations: Hb 4-8 g/100 ml, ESR 70 mm in 1 hour (Westergren). Blood urea 224, serum calcium 10-3, serum inorganic phosphate 7.3 mg/100 ml. Alkaline phosphatase 6-4 K-A units. Serum proteins: total 7 5 g/100 ml. Serum electrophoresis showed a sharp (monoclonal) peak in the P region. Urine electrophoresis showed both albumin and the sharp ,B peak. Skeletal X-rays showed diffuse osteoporosis but no osteolytic lesions. The sternal bone marrow was of poor cellularity and was infiltrated by numerous plasma cells showing primitive features.
A diagnosis of multiple myelomatosis was made. It remained to assign the myeloma protein (M component) to its appropriate immunoglobulin category. The main interest arose when the usual diagnostic antisera failed to precipitate the M component on immuno-electrophoresis, whereas an antiserum raised against the patient's urine readily did so both in her urine and in her serum.
Characterization: The myeloma protein was isolated from the patient's urine. The essential steps were (1) pervaporation, (2) salt fractionation, and (3) pevikon-block, zonal electrophoresis. The product sedimented as a single, symmetrical peak in the analytical ultracentrifuge. The sedimentation coefficient was 3-3 Svedberg units.
The diffusion coefficient was measured to be 92 x 10-7 cm2/sec. An approximate molecular weight of 42,000 was calculated for the myeloma protein.
On starch gel electrophoresis (Fig 1) the M component behaved as a light chain with the same mobility as band 8 (Cohen & Porter 1964) . Antigenic study of the myeloma protein and its homologous antiserum, by the technique of double diffusion in agar gel, revealed almost exclusively 'individual antigenic specificity' in the myeloma protein. It showed only very minor cross-reactivity with some other A Bence-Jones proteins and none with K Bence-Jones proteins, pooled normal light chains or 25 normal human sera.
Final proof of the light chain identity of the myeloma component came from a recombination experiment. The component light and heavy chains of an IgG molecule can be separated and subsequently recombined (Gally & Edelman 1964). We were able to combine the isolated M component with normal heavy chains to form an IgG globulin. Whereas the specific antiserum made against the patient's urine had been used throughout the study to 'recognize' the myeloma protein, once the latter was integrated into an intact immunoglobulin molecule, the antiserum failed totally to react with it. The individual antigenic sites had all apparently become altered or inaccessible.
The myeloma protein was thus found to be a A chain dimer, with little antigenic cross-reaction with other A chains. Its very marked, individual, antigenic specificity disappeared when it was combined with H chains to form an IgG molecule. of defecation lasting a few days occurred every few weeks and dated from a himorrhoidectomy operation in 1962. During attacks, stools pale, frothy and difficult to flush. Some lower abdominal discomfort but appetite good. As a young adult she may have been 2-3 cm taller than now. Mother similarly small, siblings all taller. Menarche aged 11 years, menopause 45 years.
On examination: Mild generalized pigmentation and pale mucous membranes. Height 145 cm (normal proportions), weight 44-1 kg.
Investigations: Hb 71 %, WBC 2,500. Film: macrocytosis and hypochromia. ESR 7 mm in 1 h (Westergren). Sternal marrow: megaloblastic changes. Serum BI, 180 pg/mI, no reticulocyte response to intramuscular B,5 therapy. Xylose absorption: 12% of 25 g dose excreted in five "Present address: Addenbrooke's Hospital, Cambridge
